We are live on ! Find out more
IGC icon

IGC Pharma
IGC

21 hedge funds and large institutions have $1.15M invested in IGC Pharma in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

65% more capital invested

Capital invested by funds: $694K → $1.15M (+$454K)

1.26% more ownership

Funds ownership: 3.63% → 4.89% (+1.3%)

0% more funds holding

Funds holding: 21 → 21 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
2
Closed
4
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
CFA
Carroll Financial Associates
North Carolina
+$163K
2
BCM
Bridgeway Capital Management
Texas
+$69K
3
Citadel Advisors
Citadel Advisors
Florida
+$16K
4
Barclays
Barclays
United Kingdom
+$3.46K
5
Group One Trading
Group One Trading
Illinois
+$2.06K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$36.2K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5K
3
Northern Trust
Northern Trust
Illinois
-$1.92K
Name Holding Trade Value Shares
Change 		Change in
Stake
CFA
1
Carroll Financial Associates
North Carolina
$308K +$163K +300,000 +140%
Vanguard Group
2
Vanguard Group
Pennsylvania
$272K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$156K – – –
BCM
4
Bridgeway Capital Management
Texas
$76K +$69K +127,200 New
VF
5
Virtu Financial
New York
$66K +$59.4K +109,493 New
DP
6
Dearborn Partners
Illinois
$62K – – –
Northern Trust
7
Northern Trust
Illinois
$54K -$1.92K -3,541 -4%
Goldman Sachs
8
Goldman Sachs
New York
$40K +$108 +200 +0.3%
Bank of Montreal
9
Bank of Montreal
Ontario, Canada
$26K – – –
SFS
10
Sowell Financial Services
Arkansas
$22K – – –
Truist Financial
11
Truist Financial
North Carolina
$22K – – –
Citadel Advisors
12
Citadel Advisors
Florida
$18K +$16K +29,459 New
BlackRock
13
BlackRock
New York
$17K -$36.2K -66,730 -71%
Barclays
14
Barclays
United Kingdom
$4K +$3.46K +6,386 New
Morgan Stanley
15
Morgan Stanley
New York
$2K +$678 +1,250 +50%
Group One Trading
16
Group One Trading
Illinois
$2K +$2.06K +3,800 +1,089%
GWM
17
Geneos Wealth Management
Colorado
$1K – – –
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
– -$5K -10,134 Closed
Wells Fargo
19
Wells Fargo
California
– +$1 +2 +0.9%
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
– +$72 +132 +108%

IGC Hedge Fund Activity: Q2 2020 in Review

21 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q2 2020, worth a combined $1.15M — up 65% from $694K a quarter earlier.

Fund positioning in IGC was balanced in Q2 2020: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 2 trimmed.

The largest buyer was Carroll Financial Associates, adding an estimated $163K. The largest seller was BlackRock, cutting an estimated $36.2K.

  • 21 institutional investors held IGC Pharma (IGC) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $1.15M of IGC Pharma stock for Q2 2020, up 65% quarter-over-quarter.
  • 4 funds opened new IGC Pharma positions in Q2 2020 and 4 closed out, a net change of 0 holders.
  • The largest IGC Pharma buyer in Q2 2020 was Carroll Financial Associates, an estimated $163K added.
  • The largest IGC Pharma seller in Q2 2020 was BlackRock, an estimated $36.2K sold.

Based on aggregated 13F filings for Q2 2020.